IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
432.36
+5.10 (1.19%)
Jan 8, 2025, 4:00 PM EST - Market closed
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 539.63, with a low estimate of 435 and a high estimate of 650. The average target predicts an increase of 24.81% from the current stock price of 432.36.
Analyst Consensus: Buy
* Price targets were last updated on Dec 2, 2024.
Analyst Ratings
The average analyst rating for IDXX stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 3 | 3 | 3 | 3 | 3 | 4 |
Hold | 3 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 7 | 7 | 7 | 7 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Initiates $500 | Buy | Initiates | $500 | +15.64% | Dec 2, 2024 |
Piper Sandler | Piper Sandler | Hold Reiterates $520 → $435 | Hold | Reiterates | $520 → $435 | +0.61% | Nov 4, 2024 |
Barclays | Barclays | Buy Maintains $570 → $481 | Buy | Maintains | $570 → $481 | +11.25% | Nov 4, 2024 |
JP Morgan | JP Morgan | Buy Maintains $630 → $575 | Buy | Maintains | $630 → $575 | +32.99% | Oct 11, 2024 |
Stifel | Stifel | Hold Maintains $510 → $500 | Hold | Maintains | $510 → $500 | +15.64% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
3.96B
from 3.66B
Increased by 8.09%
Revenue Next Year
4.24B
from 3.96B
Increased by 7.25%
EPS This Year
10.76
from 10.06
Increased by 6.98%
EPS Next Year
12.22
from 10.76
Increased by 13.57%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.1B | 4.4B | 4.8B | ||
Avg | 4.0B | 4.2B | 4.6B | ||
Low | 3.8B | 4.0B | 4.3B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.6% | 11.5% | 13.9% | ||
Avg | 8.1% | 7.3% | 8.6% | ||
Low | 3.6% | 1.5% | 1.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.59 | 12.87 | 14.63 | ||
Avg | 10.76 | 12.22 | 13.82 | ||
Low | 10.20 | 11.25 | 12.92 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 15.2% | 19.6% | 19.7% | ||
Avg | 7.0% | 13.6% | 13.1% | ||
Low | 1.4% | 4.5% | 5.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.